Fructooligosaccharides (FOS) untuk Irritable Bowel Syndrome (IBS)

Q: Does Fructooligosaccharides (FOS) help with Irritable Bowel Syndrome (IBS)?

Based on 2 studies with 150 participants, there is preliminary evidence that needs more research that Fructooligosaccharides (FOS) may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is D (Very Early Research).

Q: How much Fructooligosaccharides (FOS) should I take for Irritable Bowel Syndrome (IBS)?

Studies have used various dosages. A commonly studied range is 2-10 g/day. Always consult your healthcare provider before starting any supplement regimen.

Q: Are there side effects of Fructooligosaccharides (FOS)?

Reported side effects may include Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day), Abdominal cramping at higher doses, May worsen IBS symptoms in FODMAP-sensitive individuals, Loose stools at excessive doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

Q: How strong is the evidence for Fructooligosaccharides (FOS) and Irritable Bowel Syndrome (IBS)?

We rate the evidence as Grade D (Very Early Research). This rating is based on 2 peer-reviewed studies with 150 total participants. The overall direction of effect is mixed.

Mixed results. Low doses may help (5 g) but higher doses can worsen bloating due to rapid fermentation.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dfructooligosaccharides\u0026condition\u003Dibs'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Kesimpulan

Mixed results. Low doses may help (5 g) but higher doses can worsen bloating due to rapid fermentation.

Key Study Findings

Other

FODMAP Profile of Wholegrain Pasta.

Dose: None vs: None Outcome: FODMAP compound content in pasta (analytical) Efek: None None

Populasi: Commercially available pasta products (analytical study)

Randomized Controlled Trial n=9 12 weeks

Modification of the Low FODMAP Diet Is Feasible in the Treatment of Irritable Bowel Syndrome: …

Dose: None vs: Baseline; crossover between 3 diets Outcome: Birmingham IBS questionnaire symptom score Efek: 75% relief on low FOS+GOS; 62.5% on FODMAP p<0.05

Populasi: IBS patients (Rome IV criteria)

Other

Biotechnological Tools for the Production of Low-FODMAP Wholegrain Wheat and Rye Cookies and Crackers.

Dose: None vs: Standard wholegrain flour products Outcome: FODMAP content reduction in cookies and crackers Efek: Up to 99.5% FODMAP reduction (wheat malt) None

Populasi: Laboratory food science study (no human subjects)

Randomized Controlled Trial 12 weeks Double-blind

Efficacy and Safety of a Mixture of Microencapsulated Sodium Butyrate, Probiotics, and Short Chain Fructooligosaccharides …

Dose: None vs: Placebo Outcome: Quality of life Efek: None p = 0.023

Populasi: IBS patients

In Vitro

Microbial inulinase promotes fructan hydrolysis under simulated gastric conditions.

Dose: None vs: None Outcome: None Efek: None None

Populasi: None

Controlled Clinical Trial n=54 3.0 weeks

[Clinical efficacy of a modern probiotic for the correction of intestinal microflora in patients with …

Dose: 350 mg vs: None Outcome: IBS symptom improvement Efek: None None

Populasi: Irritable bowel syndrome with diarrhea and antibiotic-associated diarr

Key Statistics

Studi

150

Peserta

↔

Mixed

Peringkat

Referenced Papers

FODMAP Profile of Wholegrain Pasta. Other

Foods (Basel, Switzerland) 2025 3 sitasi

Biotechnological Tools for the Production of Low-FODMAP Wholegrain Wheat and Rye Cookies and Crackers. Other

Foods (Basel, Switzerland) 2025 1 sitasi

Modification of the Low FODMAP Diet Is Feasible in the Treatment of Irritable Bowel Syndrome: A Randomised Crossover Study. Other

Gastroenterology research and … 2025

Efficacy and Safety of a Mixture of Microencapsulated Sodium Butyrate, Probiotics, and Short Chain Fructooligosaccharides in Patients with Irritable Bowel … Other

Journal of clinical … 2024 4 sitasi

Microbial inulinase promotes fructan hydrolysis under simulated gastric conditions. Other

Frontiers in nutrition 2023 8 sitasi

[Clinical efficacy of a modern probiotic for the correction of intestinal microflora in patients with irritable bowel syndrome with diarrhea … Other

Voprosy pitaniia 2023

Inulin as a functional ingredient and their applications in meat products. Review

Carbohydrate polymers 2022 77 sitasi

Increased fermentable carbohydrate intake alters colonic mucus barrier function through glycation processes and increased mast cell counts. Other

FASEB journal : … 2022 16 sitasi

Effects of Microencapsulated Sodium Butyrate, Probiotics and Short Chain Fructooligosaccharides in Patients with Irritable Bowel Syndrome: A Study Protocol of … Other

Journal of clinical … 2022 12 sitasi

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effects of Multi-Strain Synbiotic in Patients with Functional Diarrhea and High Fecal … RCT

Nutrients 2022 8 sitasi

Current evidence on the therapeutic use of fiber in irritable bowel syndrome. Other

Expert review of … 2022 8 sitasi

Nutritional and anti-nutritional properties of lentil (Lens culinaris) protein isolates prepared by pilot-scale processing. Other

Food chemistry: X 2021 64 sitasi

FODMAP Fingerprinting of Bakery Products and Sourdoughs: Quantitative Assessment and Content Reduction through Fermentation. Other

Foods (Basel, Switzerland) 2021 10 sitasi

The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant … RCT

Nutrients 2020 78 sitasi

Impact of Cultivation Method and Cultivar Selection on Soluble Carbohydrates and Pungent Principles in Onions ( Allium cepa L.). Other

Journal of agricultural … 2018 13 sitasi

Effects of scFOS on the composition of fecal microbiota and anxiety in patients with irritable bowel syndrome: a randomized, double … RCT

Neurogastroenterology and motility 2017 131 sitasi

Gastrointestinal tolerance of low FODMAP oral nutrition supplements in healthy human subjects: a randomized controlled trial. RCT

Nutrition journal 2017 10 sitasi

[Contemporary dietotherapy of the irritable bowel syndrome]. Review

Voprosy pitaniia 2013

Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome. RCT

The American journal … 2000 136 sitasi

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosis yang Umum Digunakan

general:: 2-10 g/day
prebioticeffect:: 5-8 g/day for bifidogenic effect
constipationsupport:: 5-10 g/day

Batas atas: Well-tolerated up to 20 g/day; start low to avoid excess gas

Dosis yang Diteliti dalam Penelitian

Dosis	Durasi	Efek	N
None	--	Neutral	--
None	12 weeks	Positive	9
None	--	Positive	--
None	12 weeks	Positive	--
None	--	Mixed	--
350 mg	3.0 weeks	Positive	54
None	--	Mixed	--
None	--	Negative	--

Waktu terbaik diminum: With meals; divide doses throughout the day

Safety & Side Effects

Efek Samping yang Dilaporkan

⚠ Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day)
⚠ Abdominal cramping at higher doses
⚠ May worsen IBS symptoms in FODMAP-sensitive individuals
⚠ Loose stools at excessive doses

Interaksi yang Diketahui

● Other FODMAPs (cumulative fermentation effect in sensitive individuals)
● Blood sugar-lowering medications (FOS may modestly affect glycemic response)
● Calcium supplements (FOS may enhance calcium absorption)

Asupan atas yang dapat ditoleransi: Well-tolerated up to 20 g/day; start low to avoid excess gas

Selalu konsultasikan dengan tenaga kesehatan Anda sebelum memulai suplemen apa pun.Selalu konsultasikan dengan penyedia layanan kesehatan Anda sebelum memulai suplemen apa pun.

Frequently Asked Questions

Does Fructooligosaccharides (FOS) help with Irritable Bowel Syndrome (IBS)?

Based on 2 studies with 150 participants, there is preliminary evidence that needs more research that Fructooligosaccharides (FOS) may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is D (Very Early Research).

How much Fructooligosaccharides (FOS) should I take for Irritable Bowel Syndrome (IBS)?

Studies have used various dosages. A commonly studied range is 2-10 g/day. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Fructooligosaccharides (FOS)?

Reported side effects may include Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day), Abdominal cramping at higher doses, May worsen IBS symptoms in FODMAP-sensitive individuals, Loose stools at excessive doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Fructooligosaccharides (FOS) and Irritable Bowel Syndrome (IBS)?

We rate the evidence as Grade D (Very Early Research). This rating is based on 2 peer-reviewed studies with 150 total participants. The overall direction of effect is mixed.

Related Evidence

Bahan lain untuk Irritable Bowel Syndrome (IBS)

Peppermint Oil A Lactobacillus rhamnosus GG B Psyllium Husk B Lactobacillus plantarum B Partially Hydrolyzed Guar Gum (PHGG) B Bifidobacterium longum B

Fructooligosaccharides (FOS) untuk kondisi lain

Chronic Constipation C

Kesimpulan Singkat

Mixed results. Low doses may help (5 g) but higher doses can worsen bloating due to rapid fermentation.

Evidence Strength30%

Low confidence

Rincian Studi

RCT (5)Meta (0)Other (0)

Bandingkan Alternatif

Lihat bagaimana bahan lain dibandingkan untuk kondisi ini.

Lihat semua bahan untuk Irritable Bowel Syndrome (IBS)

Pelajari Lebih Lanjut

Penafian FDA: Pernyataan-pernyataan ini belum dievaluasi oleh Food and Drug Administration. Produk dan informasi di situs web ini tidak dimaksudkan untuk mendiagnosis, mengobati, menyembuhkan, atau mencegah penyakit apa pun. Peringkat bukti yang disajikan didasarkan pada analisis kami terhadap penelitian yang ditinjau sejawat dan tidak merupakan saran medis. Selalu konsultasikan dengan penyedia layanan kesehatan Anda sebelum memulai regimen suplemen apa pun.